enfortumab vedotin   

GtoPdb Ligand ID: 10738

Synonyms: ASG-22CE | enfortumab vedotin-ejfv | Padcev®
enfortumab vedotin is an approved drug (FDA (2019))
Compound class: Antibody
Comment: Enfortumab vedotin is an anti-Nectin 4 monoclonal antibody-drug conjugate [3]. The toxic payload is monomethyl auristatin E (MMAE; PubChem CID 11542188). It exhibits potent efficacy in multiple preclinical cancer models [1].
Classification
Compound class Antibody
Approved drug? Yes (FDA (2019))
International Nonproprietary Names
INN number INN
9821 enfortumab vedotin
Synonyms
ASG-22CE | enfortumab vedotin-ejfv | Padcev®
Database Links
GtoPdb PubChem SID 405067331
Search PubMed clinical trials enfortumab vedotin
Search PubMed titles enfortumab vedotin
Search PubMed titles/abstracts enfortumab vedotin